CompletedPHASE1, PHASE2NCT01083667

SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Weill Medical College of Cornell University
Principal Investigator
Dale J. Lange, M.D.
Hospital for Special Surgery/Weill Cornell Medical Center
Intervention
Pyrimethamine(drug)
Enrollment
32 enrolled
Eligibility
18 years · All sexes
Timeline
20092016

Study locations (5)

Collaborators

Muscular Dystrophy Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01083667 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials